Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
作者信息
Kurian Allison W, Griffith Kent A, Hamilton Ann S, Ward Kevin C, Morrow Monica, Katz Steven J, Jagsi Reshma
机构信息
Stanford University, Department of Medicine, Stanford, California.
University of Michigan, Department of Biostatistics, Ann Arbor.
出版信息
JAMA. 2017 Feb 7;317(5):531-534. doi: 10.1001/jama.2016.16918.
Abstract
摘要
相似文献
1
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .新诊断乳腺癌患者的基因检测与咨询
JAMA. 2017 Feb 7;317(5):531-534. doi: 10.1001/jama.2016.16918.
2
BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.接受基因检测后接受咨询的BRCA 1/2阴性患者焦虑程度较低。
Cancer. 2016 Apr 15;122(8):1149. doi: 10.1002/cncr.30002.
3
Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.对新诊断出有BRCA种系突变遗传风险的乳腺癌患者进行遗传咨询与管理。
Breast J. 2006 May-Jun;12(3):280-1; author reply 282-4. doi: 10.1111/j.1075-122X.2006.00260.x.
4
Pretest genetic counseling informs patients with BRCA mutation.检测前遗传咨询为携带BRCA突变的患者提供信息。
Cancer. 2012 Dec 15;118(24):6017. doi: 10.1002/cncr.27922.
5
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测：美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
6
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测：美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2019 Aug 20;322(7):666-685. doi: 10.1001/jama.2019.8430.
7
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.BRCA1/BRCA2咨询与检测对新诊断乳腺癌患者的影响。
J Clin Oncol. 2004 May 15;22(10):1823-9. doi: 10.1200/JCO.2004.04.086. Epub 2004 Apr 5.
8
Using genetic analysis to individualize preventive measures for breast and ovarian cancers.利用基因分析为乳腺癌和卵巢癌个体化预防措施。
Nat Clin Pract Oncol. 2006 Apr;3(4):182-3. doi: 10.1038/ncponc0456.
9
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.BRCA1/BRCA2基因突变检测在新诊断乳腺癌患者中的应用。
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1003-7. doi: 10.1158/1055-9965.EPI-03-0545.
10
BRCA1 and BRCA2 cancer risks.BRCA1和BRCA2的癌症风险。
J Clin Oncol. 2006 Jul 10;24(20):3312-3; author reply 3313-4. doi: 10.1200/JCO.2006.06.7934.
引用本文的文献
1
Trends in the Utilization of and Testing After the Introduction of a Publicly Funded Genetic Testing Program.在引入公共资助的基因检测项目后，[具体检测项目]检测的使用趋势。 （你原文中“and”前后内容缺失，请补充完整后我能更准确翻译）
Curr Oncol. 2025 Aug 6;32(8):439. doi: 10.3390/curroncol32080439.
2
Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer.国家学会指南和美国国立综合癌症网络（NCCN）指南对乳腺癌患者基因检测使用情况的影响。
Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17448-w.
3
The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study.主流基因检测途径和社会经济因素对乳腺癌患者接受种系基因检测的影响：全国性GENE-SMART研究结果
Breast Cancer Res. 2025 Jul 14;27(1):129. doi: 10.1186/s13058-025-02081-y.
4
Knowledge, attitude, and practice toward genetic testing in breast cancer patients in China.中国乳腺癌患者对基因检测的认知、态度及实践
PLoS One. 2025 May 8;20(5):e0322526. doi: 10.1371/journal.pone.0322526. eCollection 2025.
5
Integration of a Genetic Counselor into a Breast Health Center Improves Identification of Patients Needing Genetic Testing.将遗传咨询师纳入乳腺健康中心可改善对需要基因检测患者的识别。
Ann Surg Oncol. 2025 Jun;32(6):4002-4007. doi: 10.1245/s10434-025-17112-3. Epub 2025 Mar 7.
6
Attitude towards genetic testing for breast cancer susceptibility genes and choice of prevention strategies in Chinese women with or without breast cancer.中国患乳腺癌和未患乳腺癌女性对乳腺癌易感基因检测的态度及预防策略选择
Cancer Biol Med. 2025 Feb 4;22(1):28-32. doi: 10.20892/j.issn.2095-3941.2024.0519.
7
Pilot implementation study of a default genetic referral process for patients with early-onset colorectal cancer.早发性结直肠癌患者默认遗传转诊流程的试点实施研究
Genet Med Open. 2024 Nov 19;3:101902. doi: 10.1016/j.gimo.2024.101902. eCollection 2025.
8
Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing.多重基因检测后患者的乳腺癌MRI筛查
JAMA Netw Open. 2025 Jan 2;8(1):e2454447. doi: 10.1001/jamanetworkopen.2024.54447.
9
Reduced Breast and Ovarian Cancer Through Targeted Genetic Testing: Estimates Using the NEEMO Microsimulation Model.通过靶向基因检测降低乳腺癌和卵巢癌发病率：使用NEEMO微观模拟模型的估计
Cancers (Basel). 2024 Dec 13;16(24):4165. doi: 10.3390/cancers16244165.
10
Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer.评论：为何基因检测在全球范围内未得到充分利用？以遗传性乳腺癌为例。
BJC Rep. 2024 Oct 1;2(1):73. doi: 10.1038/s44276-024-00099-x.
本文引用的文献
1
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.一系列乳腺癌患者中25个癌症易感基因的胚系突变频率
J Clin Oncol. 2016 May 1;34(13):1460-8. doi: 10.1200/JCO.2015.65.0747. Epub 2016 Mar 14.
2
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.遗传/家族性高风险评估：乳腺和卵巢，第 2.2015 版。
J Natl Compr Canc Netw. 2016 Feb;14(2):153-62. doi: 10.6004/jnccn.2016.0018.
3
Multigene Panel Testing in Oncology Practice: How Should We Respond?肿瘤学实践中的多基因检测：我们应如何应对？
JAMA Oncol. 2015 Jun;1(3):277-8. doi: 10.1001/jamaoncol.2015.28.
4
A systematic review of factors that act as barriers to patient referral to genetic services.对阻碍患者转诊至基因服务机构的因素进行的系统评价。
Eur J Hum Genet. 2015 Jun;23(6):739-45. doi: 10.1038/ejhg.2014.180. Epub 2014 Sep 10.
5
Performance of BRCA1/2 mutation prediction models in Asian Americans.BRCA1/2突变预测模型在亚裔美国人中的表现。
J Clin Oncol. 2008 Oct 10;26(29):4752-8. doi: 10.1200/JCO.2008.16.8310. Epub 2008 Sep 8.
Zotero 插件